Characterize and optimize adjuvants to test monkeypox vaccines

NIH RePORTER · NIH · N01 · $1,599,006 · view on reporter.nih.gov ↗

Abstract

To identify novel classes of adjuvants, characterize and optimize them, and test them in vivo with various antigens from different pathogens.

Key facts

NIH application ID
10610275
Project number
75N93019C00045-P00012-9999-2
Recipient
UNIVERSITY OF MONTANA
Principal Investigator
JAY EVANS
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$1,599,006
Award type
—
Project period
2021-09-30 → 2022-09-29